No plans for vaccine boosters in India, however, due to high natural infection rate, say sources

India is yet to authorize booster COVID-19 doses as many people in the country have become naturally infected and the government believes that two doses of a vaccine will provide enough protection for now. , said three sources with knowledge of the matter. As the supply of the vaccine has increased, some doctors and public … Read more

Pfizer asks FDA to fix COVID-19 booster shots for all adults

US regulators on Tuesday asked anyone 18 or older to allow boosters of their COVID-19 vaccine, a move that comes amid concerns about the growing spread of the coronavirus. Older Americans, and other groups particularly hardest-hit by the virus, have had access to a third dose of the Pfizer and BioNTech vaccine since September. But … Read more

More than 11 crores of 60 plus got the first time, total coverage tops 108 crores

The Union Health Ministry said on Saturday that a total of 11,04,55,016 people above 60 years of age have been given the first dose of the COVID-19 vaccine in the country so far. However, only 6,78,27,591 people in this age group have been given both doses. As per the provisional report, India’s overall COVID-19 vaccination … Read more

Moderna finds that inventing a COVID-19 vaccine was the easy part

Moderna Inc. has some of the highest-flying science in the biotech business. It brought its messenger RNA vaccine to market less than a year later than almost no one had thought possible. But more than 10 months after US regulators authorized its potent shot, Moderna found that inventing a COVID-19 vaccine was actually a relatively … Read more

AstraZeneca withdraws request for Swiss approval of COVID-19 shot

On Thursday it said it was withdrawing its application for approval of its COVID-19 vaccine in Switzerland as the country’s medical regulator seeks to restrict its use to people over the age of 50. Switzerland has approved vaccines from BioNTech-Pfizer, Moderna and Johnson & Johnson. However, national medical regulator SwissMedic has not yet granted marketing … Read more